15807 Efficacy of tildrakizumab in patients with moderate...

15807 Efficacy of tildrakizumab in patients with moderate to severe psoriasis according to disease duration: Pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials at week 28

Thaçi, Diamant, Iversen, Lars, Pau-Charles, Ignasi, López, Andreu Schoenenberger, Blauvelt, Andrew, Puig, Lluís
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.730
Date:
December, 2020
File:
PDF, 312 KB
2020
Conversion to is in progress
Conversion to is failed